A-19
NDC 58264-0311, SOLENOPSIS INVICTA, PERIPLANETA AMERICANA, MUSCA DOMESTICA, BOMBYX MORI WHOLE, and AEDES TAENIORHYNCHUS, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0311
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SOLENOPSIS INVICTA30 [hp_X]/mL
- PERIPLANETA AMERICANA30 [hp_X]/mL
- MUSCA DOMESTICA30 [hp_X]/mL
- BOMBYX MORI WHOLE30 [hp_X]/mL
- AEDES TAENIORHYNCHUS30 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Ant Venoms [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Insect Proteins [CS]; Insect Proteins [CS]; Insect Proteins [CS]; Insect Proteins [CS]; Non-Standardized Insect Allergenic Extract [EPC]; Non-Standardized Insect Allergenic Extract [EPC]; Non-Standardized Insect Allergenic Extract [EPC]; Non-Standardized Insect Venom Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0311-1 | 58264031101 | 29.57 mL in 1 BOTTLE, GLASS (58264-0311-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0311 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.